Larimar Therapeutics Appoints Dr. Rusty Clayton as Chief Medical Officer
BALA CYNWYD, Pa., July 17, 2023 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused…
Pharmaceuticals, Biotechnology and Life Sciences
BALA CYNWYD, Pa., July 17, 2023 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused…
Completed target enrollment of 50 patients in the randomized Phase 2 Dose Expansion stage of the PRISM clinical trial over…
– The funding will support NB001 Parkin gene replacement therapy IND-enabling studies- Initial indication in a substantial, genetically defined Parkinson’s…
LOS GATOS, Calif., July 17, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced positive feedback from the…
Vivoryon Therapeutics N.V. Shares Clinical Development Update Highlighting Progress of N3pE-Amyloid-targeting Small Molecule Varoglutamstat in Alzheimer’s Disease Small molecule varoglutamstat,…
Figure 1 Acumen Pharmaceuticals, Inc. Figure 2 Acumen Pharmaceuticals, Inc. Topline results from INTERCEPT-AD trial met primary and secondary objectives,…
CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, July 14, 2023 (GLOBE NEWSWIRE) — Atlas Global Brands Inc. (“Atlas Global” or the “Company”)…
TORONTO, July 14, 2023 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or…
PALO ALTO, Calif., July 14, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused…
SAN MATEO, Calif., July 13, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing…